Propranolol in treatment of hemangioma
Phase 2
Completed
- Conditions
- Hemangioma.Hemangioma, any site
- Registration Number
- IRCT2014041817325N1
- Lead Sponsor
- Ardabil University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Patients with hemangioma under 15 years old
Exclusion criteria: Patients with cardiovascular disease; patients with history of low blood sugar; patients use another drugs last 6 months.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Regression of hemangioma (decrease in size). Timepoint: 1 week, 6month, 1 year. Method of measurement: Watchful, sonography if needed.
- Secondary Outcome Measures
Name Time Method Decrease blood sugar. Timepoint: In first visit, after 1 week. Method of measurement: With glucometer.